FR2921061B1 - Derives d'indolone pour le traitement de la malaria - Google Patents

Derives d'indolone pour le traitement de la malaria

Info

Publication number
FR2921061B1
FR2921061B1 FR0706425A FR0706425A FR2921061B1 FR 2921061 B1 FR2921061 B1 FR 2921061B1 FR 0706425 A FR0706425 A FR 0706425A FR 0706425 A FR0706425 A FR 0706425A FR 2921061 B1 FR2921061 B1 FR 2921061B1
Authority
FR
France
Prior art keywords
malaria
treatment
indolone derivatives
indolone
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0706425A
Other languages
English (en)
Other versions
FR2921061A1 (fr
Inventor
Francoise Nepveu
Jalloul Bouajila
Jeremie Boyer
Sothea Kim
Jean Pierre Nallet
Serge Jean Pierre Petit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IDEALP PHARMA
Institut de Recherche pour le Developpement IRD
Universite Toulouse III Paul Sabatier
Original Assignee
IDEALP PHARMA
Institut de Recherche pour le Developpement IRD
Universite Toulouse III Paul Sabatier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IDEALP PHARMA, Institut de Recherche pour le Developpement IRD, Universite Toulouse III Paul Sabatier filed Critical IDEALP PHARMA
Priority to FR0706425A priority Critical patent/FR2921061B1/fr
Publication of FR2921061A1 publication Critical patent/FR2921061A1/fr
Application granted granted Critical
Publication of FR2921061B1 publication Critical patent/FR2921061B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/36—Oxygen atoms in position 3, e.g. adrenochrome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
FR0706425A 2007-09-13 2007-09-13 Derives d'indolone pour le traitement de la malaria Expired - Fee Related FR2921061B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0706425A FR2921061B1 (fr) 2007-09-13 2007-09-13 Derives d'indolone pour le traitement de la malaria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0706425A FR2921061B1 (fr) 2007-09-13 2007-09-13 Derives d'indolone pour le traitement de la malaria

Publications (2)

Publication Number Publication Date
FR2921061A1 FR2921061A1 (fr) 2009-03-20
FR2921061B1 true FR2921061B1 (fr) 2009-12-18

Family

ID=39415277

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0706425A Expired - Fee Related FR2921061B1 (fr) 2007-09-13 2007-09-13 Derives d'indolone pour le traitement de la malaria

Country Status (1)

Country Link
FR (1) FR2921061B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011053697A1 (fr) 2009-10-30 2011-05-05 Genzyme Corporation Composés 2-aminoindoles et méthodes de traitement de la malaria
FR3005858A1 (fr) * 2013-05-22 2014-11-28 Univ Toulouse 3 Paul Sabatier Utilisation de nanoparticules pour la preparation de compositions antipaludeennes solubles dans l'eau et injectables

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE505711A (fr) * 1950-09-09

Also Published As

Publication number Publication date
FR2921061A1 (fr) 2009-03-20

Similar Documents

Publication Publication Date Title
FR2915201B1 (fr) Procede pour la preparation d'anhydrides polyalcenylsucciniques
DK2303330T4 (da) Farmaceutiske sammensætninger til behandling af parkinsons sygdom
FR2932478B1 (fr) Composes utiles pour le traitement des cancers.
MA28791B1 (fr) Derives de piperazine convenant pour le traitement de troubles gastro-intestinaux
ZA201006868B (en) Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease
CY2016017I2 (el) Συνθεση για θεραπεια πνευμονικης υπερτασης
IL192690A0 (en) Hydantoin derivatives for the treatment of inflammatory disorders
NO20070753L (no) Fremgangsmåte for fremstilling av dihydropteridinoner
SMAP200900055A (it) Chinazoline per l'inibizione di pdk1
SMP200800059B (it) Chinazoline per l'inibizione di pdk1
BRPI0818799A2 (pt) Composições para o tratamento da doença de parkinson
NO20076030L (no) Fremgangsmåte for fremstilling av hydroklorsilaner
ATE496924T1 (de) Prodrugs von 5-amino-3-(3'-deoxy-beta-d- ribofuranosyl)-thiazolä4,5-düpyrimidin-2,7-dion
FR2914311B1 (fr) Modification de la nuance colorante d'anthocyanes pour l'obtention de substances colorantes
BRPI0821026A2 (pt) Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos
FR2921061B1 (fr) Derives d'indolone pour le traitement de la malaria
FR2926993B1 (fr) Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme
FR2924593B1 (fr) Plaque osseuse pour le traitement de l'extremite inferieure du cubitus
FR2913976B1 (fr) Derives de la classe des hydroxyquinoleines aminees pour le traitement de cancers.
FR2899257B1 (fr) Cloison pour la realisation de cloisonnages
FR2868312B1 (fr) Patch pour le traitement des levres
FR2905252B1 (fr) Presentoir pour le support d'articles suspendus.
FR2887456B1 (fr) "composition pour le traitement de la dermite estivale"
FR2950058B1 (fr) Utilisation de derives d'indole benzoique comme activateurs de nurr-1, pour le traitement de la maladie de parkinson
MA28513B1 (fr) Processus pour la preparation d'inhibiteurs de tryptase

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20160531